Abstract
The AA. studied the glycometabolic activity of prazosin, a hypotensive drug with an adrenergic blocking activity of alpha-1-selective type. Twenty-two moderately hypertensive subjects were studied. Their ages ranged from 37 to 57 years; 10 of the patients had non-insulin dependent diabetes mellitus. After overnight fasting every patient underwent an oral glucose test (g 100) at 09:00. Blood samples were withdrawn at 0,30, 60, 90 and 120 minutes. Each patient was then given in randomized and double-blind fashion placebo or prazosin (4 mg, 2 pills of Min-ipress® Pfizer per day) for the following 7 days; then another glucose load was administered. Glucose (enzymatic method), insulin and glucagon (RIA method) were measured in each blood sample. In non diabetic subjects glucose levels (60, 90, 120 min and total area) after oral glucose and prazosin were statistically higher (p < 0.05, p < 0.01, p < 0.01, p < 0.05) than after glucose only. No significant difference between the two curves was observed in the diabetic group. IRI levels in normal subjects were statistically higher after 120 min and in the total area, while no evident changes were noted in the diabetic group. The glucagon curve seen after oral glucose was not modified by prazosin in either group.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abramson E.A., Arki R.A., Woeber K.A. Effect of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycemia. Lancet 2:1286, 1966.
Arnold A., Mac Auliff J., Colella D., O’Connor W., Brown T. Beta-2 receptor mediated glycogenoytic responses to cathecolamines in dogs. Arch. Int. Pharmacodyn. 176: 451, 1968.
Gerich J.E., Lorenzi M., Tsalikian E., Karam J.H. Studies on the mechanism of epinephrine induced hy-perglicemia in man. Diabetes 25: 65, 1976.
Kaneto A., Kajinuma H., Kosaka K. Effect of adenoreceptors stimulants infused intrapancreatically on glucagon and insulin secretion. Horm. Metab. Res. 9: 267, 1977.
Lands A.M., Arnold A., Mac Auliff J.P., Luduena F.P., Brown T.G. Differentiation of receptor sistem activated by sympatomimetic amines. Nature 214:597, 1967.
Barbieri C., Ferrari C., Caldara R., Dal Bo G.A., Paracchi A., Testori G.P., Romussi M., Cutarelli G. Effetti metabolici del prazosin In: Bartorelli C., Bertelli A., Giotti A., Teodori U. (Eds.), Problemi e prospettive dell’ipertensione arteriosa. Ed. ESAM, Roma, 1978, p. 116.
Pagano G., Montini M., Botrugno A., Borra G.C. Effetti delta stimolazione alfa-adrenergica sulla secrezi-one insulinica e sulla funzione anteipofisaria nel sogget-to sano. Atti Congresso Nazionale Società Italiana Diabetologica, 1980 (Abstract).
Fussganger R.D., Filipponi P., Quareschi M. Effect of alpha-adrenergic agonist and antagonist on insulin and glucagon secretion in the isolated, perfused rat pancreas. X Cong. Int. Diab. Fed. Wien, Excerpta Medica, Amsterdam, 1979 (Abstract).
Iversen J. Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas. J.Clin. Invest. 52: 2102, 1973.
Ditschuneit H.H., Fussganger R.D., Ditschuneit H. Lipolytic activity of sympatomimetics in isolated human fat cells. X Cong. Int. Diab. Fed. Wien, Excerpta Medica, Amsterdam, 1979 (Abstract).
Ratzman K.P., Michaelis D., Witt S., Wulfert P., Shulz B. Effect of alpha-adrenergic blocklade on insulin response to glucose infusion in protodiabetic subjects. Endocrinologie 73: 227, 1979.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferlito, S., Puleo, F., Carrà, G. et al. Effect of alpha-1-blockade by prazosin on blood sugar, insulin and glucagon levels in normals and non-insulin dependent diabetics. J Endocrinol Invest 6, 199–202 (1983). https://doi.org/10.1007/BF03350608
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350608